- Home
- SWAG vs ABVC Comparison
SWAG vs ABVC Comparison
Compare SWAG & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWAG | ABVC |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 34.6M |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | SWAG | ABVC |
|---|---|---|
| Price | $1.73 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.1K | ★ 103.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.82 | 7.14 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $116,191,000.00 | $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $28.50 | ★ N/A |
| Revenue Growth | ★ 40.58 | N/A |
| 52 Week Low | $1.50 | $0.71 |
| 52 Week High | $3.50 | $3.39 |
Technical Indicators
Market Signals| Indicator | SWAG | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 26.10 | 40.04 |
| Support Level | $1.59 | N/A |
| Resistance Level | $1.84 | $1.14 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 18.50 | 41.39 |
Price Performance
Historical ComparisonAbout SWAG Stran & Company Inc.
Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.